Senseonics Holdings, Inc. Schedules Third Quarter 2020 Earnings Release & Conference Call for November 9, 2020 at 4:30 p.m. E...
Senseonics Holdings, Inc. (NYSE-American: SENS), a medical
technology company focused on the development and commercialization
of long-term, implantable continuous glucose monitoring (CGM)
systems for people with diabetes, today announced that it plans to
release its third quarter 2020 financial results after market close
on Monday, November 9, 2020.
Management will hold a conference call to review the company’s
third quarter 2020 performance starting at 4:30 p.m. (Eastern Time)
on the same day. The conference call will be concurrently webcast.
The link to the webcast will be available on Senseonics Holdings,
Inc. website at www.senseonics.com by navigating to “Investor
Relations,” and then “Events & Publications,” and will be
archived there for future reference. To listen to the conference
call, please dial 1-888-243-4451 (US/Canada) or 1-412-542-4135
(International), passcode 4128608, approximately ten to five
minutes prior to start time.
Senseonics Holdings, Inc. is a medical technology company
focused on the design, development and commercialization of
transformational glucose monitoring products designed to help
people with diabetes confidently live their lives with ease.
Senseonics' CGM Systems, Eversense® and Eversense® XL, include a
small sensor inserted completely under the skin that communicates
with a smart transmitter worn over the sensor. The glucose data are
automatically sent every 5 minutes to a mobile app on the user's
version on businesswire.com: https://www.businesswire.com/news/home/20201028006071/en/
Senseonics Investor Contact Lynn Lewis or Philip Taylor
Investor Relations 415-937-5406 email@example.com